Phase I Analysis of the Safety and Pharmacodynamics of the Novel Broad Spectrum Histone Deacetylase Inhibitor (HDACi) PCI-24781 in Relapsed and Refractory Lymphoma. (Q127085597)
scholarly article
Language:
(P31) (Q13442814)
(P304) 2726-2726
(P407) (Q1860)
(P433) 22
(P478) 114
(P577) Friday, November 20, 2009
(P953) https://ashpublications.org/blood/article/114/22/2726/132437/Phase-I-Analysis-of-the-Safety-and
(P1433) (Q885070)
(P1476) "Phase I Analysis of the Safety and Pharmacodynamics of the Novel Broad Spectrum Histone Deacetylase Inhibitor (HDACi) PCI-24781 in Relapsed and Refractory Lymphoma." (language: en)
(P2093) Andrew M Evens
Weiyun Ai
Sriram Balasubramanian
Mint Sirisawad
Chitra Mani
Martha Guerra
Nancy Szakacs
David Loury
Joseph J Buggy
Ahmed Hamdy
Julie M. Vose
Nancy L Bartlett
other details
description scholarly article

External Links